Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pier Francesco Bassi
ElectroMotive Drug Administration (EMDA) of Mitomycin C as First-Line Salvage Therapy in High Risk “BCG Failure” Non Muscle Invasive Bladder Cancer: 3 Years Follow-Up Outcomes
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Pd66-03 Sequential Administration of BCG and Electromotive Drug Administration (Emda) of Mitomycin C (Mmc) in Non-Muscle Invasive Bladder Cancer Having Previously Received Intravesical Therapy
Journal of Urology
Urology
Compared Efficacy of Intravesical BCG vs Mitomycin-C, and Other Dual Therapies in Non-Muscle Invasive Bladder Cancer
Cancer therapy & Oncology International Journal
Systematic Review and Cumulative Analysis of the Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer
Scientific Reports
Multidisciplinary
Lba27 Phase 3 Study of Vicinium in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Initial Results
Journal of Urology
Urology
IL-9 BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer in Europe
Japanese Journal of Urology
Urology
Investigation of the Mechanisms of Action Behind Electromotive Drug Administration (EMDA)
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Comparison of Intravesical Bacillus Calmette‑Guerin and Mitomycin C Administration for Non‑muscle Invasive Bladder Cancer: A Meta‑analysis and Systematic Review
Oncology Letters
Cancer Research
Oncology
Systemic Inflammatory Markers and Oncologic Outcomes in Patients With High-Risk Non–muscle-Invasive Urothelial Bladder Cancer
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Multi-Institutional Analysis of Sequential Intravesical Gemcitabine and Mitomycin C Chemotherapy for Non–muscle Invasive Bladder Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
